Re: Letter written in reaction to "Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database", by Pottegård et al. - The authors (Asomaning et al.) respond.
作者信息
Asomaning K, Abramsky S, Liu Q, Zhou X, Sobel R E, Watt S
机构信息
Department of Epidemiology, Pfizer Inc, New York, NY, USA.
Department of Medical Affairs, Pfizer Inc, New York, NY, USA.
出版信息
Int J Clin Pract. 2016 Aug;70(8):697-8. doi: 10.1111/ijcp.12848.